A phase I/II trial of celecoxib with chemotherapy and radiotherapy in the treatment of patients with locally advanced oesophageal cancer

By Dawson S.   Michael M.   Biagi J.   Foo K.   Jefford M.   Ngan S.   Leong T.   Hui A.   Milner A.   Thomas R.   Zalcberg J.  

Investigational New Drugs, Vol. 25, Iss. 2, 2007-04 ,pp. : 123-129

Springer Publishing Company

Access to resources Recommend Favorite

Phase II Trial of SarCNU in Malignant Glioma: Unexpected Pulmonary Toxicity with a Novel Nitrosourea: A phase II trial of the national cancer institute of canada clinical trials group

By Webster Marc   Cairncross Gregory   Gertler Stan   Perry James   Wainman Nancy   Eisenhauer Elizabeth  

Investigational New Drugs, Vol. 23, Iss. 6, 2005-12 ,pp. : 591-596

Springer Publishing Company

Access to resources Recommend Favorite

A phase II trial of gefitinib for recurrent or metastatic cancer of the esophagus or gastroesophageal junction

By Adelstein David  

Investigational New Drugs, Vol. 30, Iss. 4, 2012-08 ,pp. : 1684-1689

Springer Publishing Company

Access to resources Recommend Favorite

Phase II trial of R115777 (NSC #70818) in patients with advanced colorectal cancer: A Southwest Oncology Group study

By Whitehead Robert   McCoy Sheryl   Macdonald John   Rivkin Saul   Neubauer Marcus   Dakhil Shaker   Lenz Heinz-Josef   Tanaka Michael   Abbruzzese James  

Investigational New Drugs, Vol. 24, Iss. 4, 2006-07 ,pp. : 335-341

Springer Publishing Company

Access to resources Recommend Favorite

BBR 3438, a novel 9-aza-anthrapyrazole, in patients with advanced gastric cancer: A phase II study group trial of the central European Society of Anticancer-Drug Research (CESAR)

By Hofheinz R.-D.   Porta C.   Hartung G.   Santoro A.   Hanauske A.-R.   Kutz K.   Stern A.   Barbieri P.   Verdi E.   Hehlmann R.   Hochhaus A.  

Investigational New Drugs, Vol. 23, Iss. 4, 2005-08 ,pp. : 363-368

Springer Publishing Company

Access to resources Recommend Favorite